{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:21:13Z","timestamp":1789172473461,"version":"build-2803163510"},"reference-count":43,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"unspecified","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2024,12,26]]},"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Elevated glycosylated hemoglobin (HbA1c) in individuals with type 2 diabetes is associated with increased risk of hospitalization and death after acute COVID-19, however the effect of HbA1c on Long COVID is unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Evaluate the association of glycemic control with the development of Long COVID in patients with type 2 diabetes (T2D).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Research design and methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study using electronic health record data from the National COVID Cohort Collaborative. Our cohort included individuals with T2D from eight sites with longitudinal natural language processing (NLP) data. The primary outcome was death or new-onset recurrent Long COVID symptoms within 30\u2013180\u2009days after COVID-19. Symptoms were identified as keywords from clinical notes using NLP in respiratory, brain fog, fatigue, loss of smell\/taste, cough, cardiovascular and musculoskeletal symptom categories. Logistic regression was used to evaluate the risk of Long COVID by HbA1c range, adjusting for demographics, body mass index, comorbidities, and diabetes medication. A COVID-negative group was used as a control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 7430 COVID-positive patients, 1491 (20.1%) developed symptomatic Long COVID, and 380 (5.1%) died. The primary outcome of death or Long COVID was increased in patients with HbA1c 8% to &lt;10% (OR 1.20, 95% CI 1.02 to 1.41) and \u226510% (OR 1.40, 95% CI 1.14 to 1.72) compared with those with HbA1c 6.5% to &lt;8%. This association was not seen in the COVID-negative group. Higher HbA1c levels were associated with increased risk of Long COVID symptoms, especially respiratory and brain fog. There was no association between HbA1c levels and risk of death within 30\u2013180\u2009days following COVID-19. NLP identified more patients with Long COVID symptoms compared with diagnosis codes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Poor glycemic control (HbA1c\u22658%) in people with T2D was associated with higher risk of Long COVID symptoms 30\u2013180\u2009days following COVID-19. Notably, this risk increased as HbA1c levels rose. However, this association was not observed in patients with T2D without a history of COVID-19. An NLP-based definition of Long COVID identified more patients than diagnosis codes and should be considered in future studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjdrc-2024-004536","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T12:32:29Z","timestamp":1738672349000},"page":"e004536","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Association of glycemic control with Long COVID in patients with type 2 diabetes: findings from the National COVID Cohort Collaborative (N3C)"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5851-6075","authenticated-orcid":false,"given":"Samuel","family":"Soff","sequence":"first","affiliation":[{"name":"Stony Brook University Renaissance School of Medicine, Stony Brook, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2144-8480","authenticated-orcid":false,"given":"Yun Jae","family":"Yoo","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5858-2080","authenticated-orcid":false,"given":"Carolyn","family":"Bramante","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, University of Minnesota Medical School, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8620-1003","authenticated-orcid":false,"given":"Jane E B","family":"Reusch","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Diabetes, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0670-4845","authenticated-orcid":false,"given":"Jared Davis","family":"Huling","sequence":"additional","affiliation":[{"name":"Biostatistics, University of Minnesota Twin Cities, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6263-440X","authenticated-orcid":false,"given":"Margaret A","family":"Hall","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8095-547X","authenticated-orcid":false,"given":"Daniel","family":"Brannock","sequence":"additional","affiliation":[{"name":"RTI International, Research Triangle Park, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9204-7177","authenticated-orcid":false,"given":"Til","family":"Sturmer","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6419-0008","authenticated-orcid":false,"given":"Zachary","family":"Butzin-Dozier","sequence":"additional","affiliation":[{"name":"School of Public Health, University of California Berkeley, Berkeley, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3108-7324","authenticated-orcid":false,"given":"Rachel","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Stony Brook University Renaissance School of Medicine, Stony Brook, New York, USA"},{"name":"Department of Internal Medicine, Stony Brook University Renaissance School of Medicine, Stony Brook, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2723-5902","authenticated-orcid":false,"given":"Richard","family":"Moffitt","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"key":"2025073112245062000_13.1.e004536.1","unstructured":"WHO COVID-19 Dashboard . COVID-19 cases. 2024. Available: https:\/\/data.who.int\/dashboards\/covid19\/cases"},{"key":"2025073112245062000_13.1.e004536.2","doi-asserted-by":"publisher","DOI":"10.1113\/EP090802"},{"key":"2025073112245062000_13.1.e004536.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.8823"},{"key":"2025073112245062000_13.1.e004536.4","doi-asserted-by":"crossref","unstructured":"Zhang HG , Honerlaw JP , Maripuri M , et al . Characterizing the use of the icd-10 code for long covid in 3 us healthcare systems. Health Informatics [Preprint] 2023. doi:10.1101\/2023.02.12.23285701","DOI":"10.1101\/2023.02.12.23285701"},{"key":"2025073112245062000_13.1.e004536.5","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-33573-6","article-title":"Post-acute sequelae of SARS-CoV-2 with clinical condition definitions and comparison in a matched cohort","volume":"13","author":"Horberg","year":"2022","journal-title":"Nat Commun"},{"key":"2025073112245062000_13.1.e004536.6","doi-asserted-by":"crossref","first-page":"103951","DOI":"10.1016\/j.jbi.2021.103951","article-title":"PASCLex: A comprehensive post-acute sequelae of COVID-19 (PASC) symptom lexicon derived from electronic health record clinical notes","volume":"125","author":"Wang","year":"2022","journal-title":"J Biomed Inform"},{"key":"2025073112245062000_13.1.e004536.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.04.021"},{"key":"2025073112245062000_13.1.e004536.8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1177\/1932296820924469","article-title":"Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States","volume":"14","author":"Bode","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"2025073112245062000_13.1.e004536.9","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-022-01259-3"},{"key":"2025073112245062000_13.1.e004536.10","first-page":"1170","article-title":"Clinical Characteristics and Outcomes of Type 2 Diabetes Patients Infected with COVID-19: A Retrospective Study","volume":"6","author":"Chen","year":"2020","journal-title":"Engineering (Beijing)"},{"key":"2025073112245062000_13.1.e004536.11","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.14570","article-title":"Effect of hyperglycemia on the immune function of COVID-19 patients with type 2 diabetes mellitus: a retrospective study","volume":"10","author":"Wang","year":"2022","journal-title":"PeerJ"},{"key":"2025073112245062000_13.1.e004536.12","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.2337\/dc21-2186","article-title":"Glycemic Control and Clinical Outcomes in U.S. Patients With COVID-19: Data From the National COVID Cohort Collaborative (N3C) Database","volume":"45","author":"Wong","year":"2022","journal-title":"Diabetes Care"},{"key":"2025073112245062000_13.1.e004536.13","doi-asserted-by":"publisher","DOI":"10.1900\/RDS.2014.11.138"},{"key":"2025073112245062000_13.1.e004536.14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7258.405"},{"key":"2025073112245062000_13.1.e004536.15","doi-asserted-by":"crossref","first-page":"e532","DOI":"10.1016\/S2589-7500(22)00048-6","article-title":"Identifying who has long COVID in the USA: a machine learning approach using N3C data","volume":"4","author":"Pfaff","year":"2022","journal-title":"Lancet Digit Health"},{"key":"2025073112245062000_13.1.e004536.16","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102607","article-title":"The prevalence of long COVID in people with diabetes mellitus-evidence from a UK cohort","volume":"71","author":"Heald","year":"2024","journal-title":"EClinicalMedicine"},{"key":"2025073112245062000_13.1.e004536.17","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.46783","article-title":"Rates of ICD-10 Code U09.9 Documentation and Clinical Characteristics of VA Patients With Post-COVID-19 Condition","volume":"6","author":"Wander","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2025073112245062000_13.1.e004536.18","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-023-02737-6","article-title":"Coding long COVID: characterizing a new disease through an ICD-10 lens","volume":"21","author":"Pfaff","year":"2023","journal-title":"BMC Med"},{"key":"2025073112245062000_13.1.e004536.19","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/s41591-023-02274-y","article-title":"Potential pitfalls in the use of real-world data for studying long COVID","volume":"29","author":"Zhang","year":"2023","journal-title":"Nat Med"},{"key":"2025073112245062000_13.1.e004536.20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.thromres.2021.04.020","article-title":"A comparison of natural language processing to ICD-10 codes for identification and characterization of pulmonary embolism","volume":"203","author":"Johnson","year":"2021","journal-title":"Thromb Res"},{"key":"2025073112245062000_13.1.e004536.21","unstructured":"Yuanda Zhu Georgia Institute of Technology, Aishwarya Mahale Georgia Institute of Technology, Kourtney Peters Emory University . Using natural language processing on free-text clinical notes to identify patients with long-term covid effects. Available: https:\/\/dl.acm.org\/doi\/10.1145\/3535508.3545555 [Accessed 26 Mar 2024]."},{"key":"2025073112245062000_13.1.e004536.22","doi-asserted-by":"crossref","unstructured":"Sch\u00f6ning V , Liakoni E , Drewe J , et al . Automatic identification of risk factors for sars-cov-2 positivity and severe clinical outcomes of covid-19 using data mining and natural language processing. Health Informatics [Preprint] 2021. doi:10.1101\/2021.03.25.21254314","DOI":"10.1101\/2021.03.25.21254314"},{"key":"2025073112245062000_13.1.e004536.23","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.16901","article-title":"Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative","volume":"4","author":"Bennett","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2025073112245062000_13.1.e004536.24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/jamia\/ocaa196","article-title":"The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment","volume":"28","author":"Haendel","year":"2021","journal-title":"J Am Med Inform Assoc"},{"key":"2025073112245062000_13.1.e004536.25","unstructured":"github . N3C nlp documentation. January 2022 Available: https:\/\/github.com\/OHNLP\/N3C-NLP-Documentation\/wiki"},{"key":"2025073112245062000_13.1.e004536.26","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18084350","article-title":"Long Covid-19: Proposed Primary Care Clinical Guidelines for Diagnosis and Disease Management","volume":"18","author":"Sis\u00f3-Almirall","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2025073112245062000_13.1.e004536.27","unstructured":"N3C concept set - 21890932 (SARS-COV-2 qual results-negative). 2023. Available: http:\/\/dx.doi.org\/10.5281\/zenodo.10231330"},{"key":"2025073112245062000_13.1.e004536.28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0286371","article-title":"Before and after COVID-19: Changes in symptoms and diagnoses in 13,033 adults","volume":"19","author":"Butler","year":"2024","journal-title":"PLoS One"},{"key":"2025073112245062000_13.1.e004536.29","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.12.05014","article-title":"Symptoms and signs of long COVID: A rapid review and meta-analysis","volume":"12","author":"Healey","year":"2022","journal-title":"J Glob Health"},{"key":"2025073112245062000_13.1.e004536.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2020.03.004"},{"key":"2025073112245062000_13.1.e004536.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2012.09.017"},{"key":"2025073112245062000_13.1.e004536.32","unstructured":"N3C concept set - 708775231 (Long-COVID (PASC)). 2023. Available: http:\/\/dx.doi.org\/10.5281\/zenodo.10231302"},{"key":"2025073112245062000_13.1.e004536.33","doi-asserted-by":"publisher","DOI":"10.2337\/db21-0329"},{"key":"2025073112245062000_13.1.e004536.34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.20517\/mtod.2022.30","article-title":"Long COVID-19 and diabetes mellitus: a short review","volume":"3","author":"Kreutzenberg","year":"2023","journal-title":"Metab Target Organ Damage"},{"key":"2025073112245062000_13.1.e004536.35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0140-6736(09)61969-3","article-title":"Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study","volume":"375","author":"Currie","year":"2010","journal-title":"The Lancet"},{"key":"2025073112245062000_13.1.e004536.36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291401"},{"key":"2025073112245062000_13.1.e004536.37","doi-asserted-by":"crossref","first-page":"569","DOI":"10.7326\/M17-0939","article-title":"Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians","volume":"168","author":"Qaseem","year":"2018","journal-title":"Ann Intern Med"},{"key":"2025073112245062000_13.1.e004536.38","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-S013"},{"key":"2025073112245062000_13.1.e004536.39","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1056\/NEJMe2407575","article-title":"Viral Variants, Vaccinations, and Long Covid - New Insights","volume":"391","author":"Rosen","year":"2024","journal-title":"N Engl J Med"},{"key":"2025073112245062000_13.1.e004536.40","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.jacc.2024.08.007","article-title":"The Effect of Semaglutide on Mortality and COVID-19-Related Deaths: An Analysis From the SELECT Trial","volume":"84","author":"Scirica","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2025073112245062000_13.1.e004536.41","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00299-2"},{"key":"2025073112245062000_13.1.e004536.42","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2147\/CLEP.S458901","article-title":"Risk of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Among Patients with Type 2 Diabetes Mellitus on Anti-Hyperglycemic Medications","volume":"16","author":"Olawore","year":"2024","journal-title":"Clin Epidemiol"},{"key":"2025073112245062000_13.1.e004536.43","doi-asserted-by":"crossref","first-page":"S276","DOI":"10.2337\/dcS13-2023","article-title":"Obesity paradox does exist","volume":"36 Suppl 2","author":"Hainer","year":"2013","journal-title":"Diabetes Care"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2024-004536","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T19:25:02Z","timestamp":1753989902000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2024-004536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,2,4]]},"published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1136\/bmjdrc-2024-004536"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2024-004536","relation":{},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}